PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.14−0.06 (-5.42%)
Close on Nov 20, 2026Market cap $9.08MP/E –Yield –
PAVmed free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
PAVmed's free cash flow for the twelve months ending Jun 30, 2026 was -$7.78M. For fiscal 2025 it was -$5.24M. The highest annual figure on record is -$4.48M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.24M | – |
| FY2024 | Dec 31, 2024 | -$33.61M | – |
| FY2023 | Dec 31, 2023 | -$52.28M | – |
| FY2022 | Dec 31, 2022 | -$72.53M | – |
| FY2021 | Dec 31, 2021 | -$42.06M | – |
| FY2020 | Dec 31, 2020 | -$21.97M | – |
| FY2019 | Dec 31, 2019 | -$13.38M | – |
| FY2018 | Dec 31, 2018 | -$8.81M | – |
| FY2017 | Dec 31, 2017 | -$6.61M | – |
| FY2016 | Dec 31, 2016 | -$4.48M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.64M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.57M | -1838.9% |
| Q3 FY2025 | Sep 30, 2025 | -$899.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.59M | – |
| Q4 FY2024 | Dec 31, 2024 | $90.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.89M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.66M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.15M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.11M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.73M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.39M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.66M | – |
| Q2 FY2022 | Jun 30, 2022 | -$22.91M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.84M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.05M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.05M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.75M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.74M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.84M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.79M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.09M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.88M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.54M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.87M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.02M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.59M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.37M | – |
| Q2 FY2017 | Jun 30, 2017 | -$823.60K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.83M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.20M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.23M | – |
See a number that looks wrong?